keyword
https://read.qxmd.com/read/38601468/effect-of-uric-acid-reduction-on-chronic-kidney-disease-systematic-review-and-meta-analysis
#1
Alfredo G Casanova, Ana I Morales, Laura Vicente-Vicente, Francisco J López-Hernández
Accumulating evidence suggests that hyperuricemia is a pathological factor in the development and progression of chronic kidney disease. However, the potential benefit afforded by the control of uric acid (UA) is controversial. Individual studies show discrepant results, and most existing meta-analysis, especially those including the larger number of studies, lack a placebo or control group as they aim to compare efficacy between drugs. On these grounds, we performed a me-ta-analysis restricted to studies including the action of any anti-gout therapies referenced to a control or placebo arm...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38457582/intensive-urate-lowering-with-pegloticase-plus-methotrexate-co-therapy-in-uncontrolled-gout-patients-with-and-without-chronic-kidney-disease-a-retrospective-case-series
#2
JOURNAL ARTICLE
John Albert, Aaron Broadwell, Lissa Padnick-Silver, Brad Marder, Brian LaMoreaux
Chronic kidney disease (CKD) and gout commonly co-occur. Pegloticase lowers serum urate (SU) in uncontrolled gout patients but antidrug antibodies limit urate-lowering response and increase infusion reaction (IR) risk. Methotrexate (MTX) co-administration increases pegloticase response rate and mitigates IR risk but CKD limits MTX use. This pooled case series examined pegloticase + MTX co-therapy in uncontrolled gout patients with and without CKD. Cases of pegloticase + MTX co-therapy in existing datasets were retrospectively examined...
March 8, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38076128/the-molecular-mechanism-of-neutrophil-extracellular-traps-and-its-role-in-bone-and-joint-disease
#3
REVIEW
Mengting Xiang, Meng Yin, Siwen Xie, Liang Shi, Wei Nie, Bin Shi, Gongchang Yu
As the body's first line of defense, neutrophils play an important role in the early stages of infection. Neutrophil extracellular traps (NETs), a novel way to kill pathogens, are released from activated neutrophils to trap and kill microorganisms and protect the body from invasion. However, studies have shown that NETs not only play a role in self-defense in vivo but also participate in some pathological processes. Current studies have found that excessive or abnormally activated NETs play a pathogenic role in a variety of diseases...
December 2023: Heliyon
https://read.qxmd.com/read/38060535/single-nucleotide-polymorphisms-link-gout-with-health-related-lifestyle-factors-in-korean-cohorts
#4
JOURNAL ARTICLE
Hye Kyung Jeon, Hae Young Yoo
Gout-a very painful inflammatory arthritis caused by the deposition of monosodium urate crystals in the joints-is influenced by several factors. We identified the association of single- nucleotide polymorphisms (SNPs) that link gout with health-related lifestyle factors using genomic data from the Korean Genome and Epidemiology Study. We conducted a genome-wide association study (GWAS) on 18,927 samples of 438 Korean patients with gout and 18,489 controls for the discovery stage. For the replication stage, another batch containing samples of 326 patients with gout and 2,737 controls were analyzed...
2023: PloS One
https://read.qxmd.com/read/38042803/comparative-study-of-trimming-and-resection-of-diseased-finger-superficial-flexor-tendons-in-gouty-carpal-tunnel-syndrome
#5
JOURNAL ARTICLE
Jinquan Liu, Fengming Gu, Qianyuan Liu, Wenxuan Chen, Qiuwen Ying, Yi Xu, Aiping Zhu, Li Tang, Danfeng Jing, Zhonghua Xu, Xiaoyun Pan, Jingyi Mi
BACKGROUND: Hyperuricemia can lead to synovial hyperplasia in the wrist. In severe cases, it can lead to the deposition of gouty stone in the carpal tunnel, resulting in increased pressure in the carpal tunnel and compression of the median nerve to cause carpal tunnel syndrome (CTS), which is called gouty carpal tunnel syndrome (GCTS). As for the surgical treatment of gouty carpal tunnel syndrome, scholars have different opinions on whether it is necessary to remove the superficial flexor tendon...
December 2, 2023: BMC Musculoskeletal Disorders
https://read.qxmd.com/read/38036062/febuxostat-dose-requirement-according-to-renal-function-in-patients-who-achieve-target-serum-urate-levels-a-retrospective-cohort-study
#6
JOURNAL ARTICLE
Young-Eun Kim, Soo Min Ahn, Ji Seon Oh, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo, Seokchan Hong
OBJECTIVES: To determine the febuxostat dose requirement according to renal function in patients who achieve target serum urate (SU) levels Methods: Of 3,153 gout patients who underwent febuxostat treatment, 873 patients with an initial SU level > 6 mg/dL were included and categorized by the estimated glomerular filtration rate: normal, chronic kidney disease (CKD) stage 3, and stages 4-5. 95 patients with insufficient follow-up were further excluded. The dose of febuxostat in patients who achieved the SU target (< 6 mg/dL) was defined as the average daily dosage at the time of SU target achievement...
November 28, 2023: Joint, Bone, Spine: Revue du Rhumatisme
https://read.qxmd.com/read/38027261/two-sides-of-the-same-coin-a-complex-presentation-of-autosomal-dominant-tubulointerstitial-kidney-diseases-a-literature-review-and-case-reports
#7
Margareta Fistrek Prlic, Sanda Huljev Frkovic, Bodo Beck, Ivana Tonkovic Durisevic, Stela Bulimbasic, Marijana Coric, Lovro Lamot, Ema Ivandic, Ivana Vukovic Brinar
INTRODUCTION: Genetic kidney diseases are underdiagnosed; namely, from 7% to 40% of patients suffering from chronic kidney disease (CKD) can carry a pathogenic variant, depending on population characteristics. Hereditary tubulointerstitial kidney diseases, including autosomal dominant tubulointerstitial kidney diseases (ADTKD), are even more challenging to diagnose. ADTKD is a rare form of genetic kidney disease resulting from pathogenic variants in the MUC1, UMOD, HNF1B, REN, SEC61A1, and DNAJB11 genes...
2023: Frontiers in Pediatrics
https://read.qxmd.com/read/38015022/lumbosacral-paravertebral-tophaceous-gout-on-an-adolescent-mimicking-malignant-neoplasm-in-18f-fdg-pet-ct
#8
JOURNAL ARTICLE
Benzheng Jiao, Shanshan Liu, Yuying Zhuang, Shuangyan Zhao, Hongguang Zhao
Contrast-enhanced MRI was performed on a 17-year-old adolescent boy with chronic lumbar and lower-limb pain, which had worsened over the past 3 days. It revealed a suspicious malignant mass adjacent to right appendage of L5-S1 vertebrae, with mixed signals and heterogeneous and obvious enhancement. 18F-FDG PET/CT was subsequently performed for staging. It showed an FDG-avid mass with mixed density in right psoas major muscle, involving adjacent appendage of L5-S1 vertebrae. Histopathological examination confirmed the mass to be gouty tophus, characterized by nodular homogeneous pink amorphous deposits around the cartilage tissue, surrounded by histiocytes and multinucleated giant cells...
November 27, 2023: Clinical Nuclear Medicine
https://read.qxmd.com/read/38008164/gout-induced-cervical-deformity-and-progressive-myelopathy-mimicking-infection-requiring-cervical-reconstruction
#9
JOURNAL ARTICLE
Philip K Louie, Rakesh Kumar, Steven Ruhoy, Venu M Nemani
INTRODUCTION: This study describes a rare case where gout, a condition primarily associated with joint inflammation, initially manifested as a progressive cervical kyphotic deformity, mimicking infection and causing myelopathy. The patient, a previously healthy 56-year-old female, presented with severe jaw pain and a temporomandibular joint (TMJ) abscess, alongside two months of worsening balance and arm/hand tingling. Extensive clinical and radiographic assessments revealed a severe cervical kyphotic deformity with bony erosion at multiple vertebral levels, raising suspicion of an infectious cause of compressive myelopathy...
November 24, 2023: World Neurosurgery
https://read.qxmd.com/read/37994776/overview-of-the-pharmacokinetics-and-pharmacodynamics-of-urat1-inhibitors-for-the-treatment-of-hyperuricemia-and-gout
#10
REVIEW
Zihan Hou, Aijinxiu Ma, Jiale Mao, Danni Song, Xu Zhao
INTRODUCTION: Hyperuricemia is a common metabolic disease, which is a risk factor for gouty arthritis and ureteral stones and may also lead to cardiovascular and chronic kidney disease (CDK). Therefore, hyperuricemia should be treated early. Xanthine oxidase inhibitors (XOIs) and uricosuric agents (UAs), which target uric acid, are two types of medications that are used to treat gout and hyperuricemia. XOIs stop the body from producing excessive uric acid, while UAs eliminate it rapidly via the kidneys...
November 23, 2023: Expert Opinion on Drug Metabolism & Toxicology
https://read.qxmd.com/read/37969458/gouty-tenosynovitis-with-compartment-syndrome-in-the-hand-a-case-report
#11
Dong Yun Lee, SuRak Eo, SooA Lim, Jung Soo Yoon
BACKGROUND: Gout is a common type of inflammatory arthritis caused by the deposition of monosodium urate crystals in the joints and surrounding tissues. It typically appears with abrupt and intense pain, redness, and swelling in the affected joint. It frequently targets the lower extremities, such as the big toe. However, rarely, gout can manifest in atypical locations, including the hands, leading to an uncommon presentation known as gouty tenosynovitis. However, it can result in significant morbidity owing to the potential for severe complications, such as myonecrosis and compartment syndrome...
October 26, 2023: World Journal of Clinical Cases
https://read.qxmd.com/read/37945285/impact-of-hyperuricaemia-on-patients-with-psoriatic-arthritis-treated-with-secukinumab-in-the-future-2-5-and-maximise-studies
#12
JOURNAL ARTICLE
Renaud Felten, Laura Widawski, Lionel Spielmann, Corine Gaillez, Weibin Bao, Jacques-Eric Gottenberg, Pierre-Marie Duret, Laurent Messer
OBJECTIVES: Patients with psoriatic arthritis (PsA) are at a significantly increased risk of hyperuricaemia and development of gout, and those with hyperuricaemia have been found to respond poorly to PsA treatment and have more peripheral and destructive joint damage. We present a comprehensive post hoc analysis using pooled data from the FUTURE 2-5 studies and the MAXIMISE study to further evaluate the impact of hyperuricaemia on clinical presentation/disease severity and response to secukinumab in patients with PsA...
November 2023: RMD Open
https://read.qxmd.com/read/37808337/flexor-tendon-rupture-secondary-to-gout
#13
JOURNAL ARTICLE
Jeremy V Lynn, Amy L Strong, Kevin C Chung
Extra-articular deposition of monosodium urate crystals is a widely recognized manifestation of gout. However, gouty infiltration of flexor tendons in the hand resulting in tendon rupture is exceedingly rare. This case report highlights a patient with gouty infiltration of flexor tendons in the right middle finger resulting in rupture of both the flexor digitorum profundus and flexor digitorum superficialis. Given the extent of gouty infiltration and need for pulley reconstruction, the patient was treated with two-stage flexor tendon reconstruction...
September 2023: Archives of Plastic Surgery
https://read.qxmd.com/read/37780654/arthroscopic-sesamoidectomy-and-plantar-metatarsal-head-bone-shaving-in-management-of-first-metatarsal-head-metatarsalgia-after-first-metatarsophalangeal-fusion
#14
JOURNAL ARTICLE
Sui Kit Chan, Tun Hing Lui
First metatarsophalangeal arthrodesis has been used to treat end-stage arthritis of the great toe (e.g., gout, post-traumatic, infection), severe hallux valgus deformity, hallux valgus caused by neuromuscular disorders, rheumatoid forefoot deformity, primary hallux varus, and rigid plantarflexion deformities, as well as a salvage procedure for failed previous operation of the great toe. As with any arthrodesis procedure, proper positioning of the hallux in first metatarsophalangeal arthrodesis is of utmost importance for good clinical outcome...
September 2023: Arthroscopy Techniques
https://read.qxmd.com/read/37756161/msu-crystal-deposition-contributes-to-inflammation-and-immune-responses-in-gout-remission
#15
JOURNAL ARTICLE
Hongchen Gu, Hanqing Yu, Ling Qin, Hanjie Yu, Yaxiang Song, Guangqi Chen, Dake Zhao, Shu Wang, Wen Xue, Ling Wang, Zisheng Ai, Bei Xu, Ai Peng
As a prominent feature of gout, monosodium urate (MSU) crystal deposition induces gout flares, but its impact on immune inflammation in gout remission remains unclear. Using single-cell RNA sequencing (scRNA-seq), we characterize the transcription profiling of peripheral blood mononuclear cells (PBMCs) among intercritical remission gout, advanced remission gout, and normal controls. We find systemic inflammation in gout remission with MSU crystal deposition at the intercritical and advanced stages, evidenced by activated inflammatory pathways, strengthened inflammatory cell-cell interactions, and elevated arachidonic acid metabolic activity...
September 26, 2023: Cell Reports
https://read.qxmd.com/read/37559414/changes-in-urinary-uric-acid-concentration-after-dotinurad-administration-to-patients-with-hyperuricemia-a-post-hoc-analysis-of-two-clinical-trials-in-japan
#16
JOURNAL ARTICLE
Toshinari Takahashi, Minoru Sasaki, Toru Shimizu, Satoshi Yamaguchi
Dotinurad has been approved in Japan as a selective urate reabsorption inhibitor for the treatment of gout and hyperuricemia. The relationship between uric acid crystallization and the use of uricosuric drugs is widely acknowledged; however, the relationship between changes in urinary uric acid concentration and urine pH or volume has not been sufficiently analyzed. Therefore, we investigated the changes in urinary uric acid concentration following dotinurad administration as well as the relationship between urine pH or volume and urinary uric acid concentration...
August 9, 2023: Clinical Pharmacology in Drug Development
https://read.qxmd.com/read/37334544/urate-lowering-drugs-for-chronic-kidney-disease-with-asymptomatic-hyperuricemia-and-hypertension-a-randomized-trial
#17
RANDOMIZED CONTROLLED TRIAL
Kentaro Kohagura, Atsushi Satoh, Masako Kochi, Takuto Nakamura, Ryo Zamami, Takeshi Tana, Kazushi Kinjyo, Ryo Funakoshi, Masanobu Yamazato, Akio Ishida, Atsushi Sakima, Kunitoshi Iseki, Hisatomi Arima, Yusuke Ohya
INTRODUCTION: Xanthine oxidase (XO) inhibitors may slow down chronic kidney disease (CKD) progression. The comparative effectiveness of the different urate-lowering drugs is unknown. The aim of this study was to determine whether urate-lowering therapy with an XO inhibitor (febuxostat) and that with a uricosuric drug (benzbromarone) are comparable in slowing renal function decline in patients with CKD complicated with hypertension and hyperuricemia. METHODS: This study was an open-label randomized parallel-group clinical trial of 95 patients with stage G3 CKD in Japan...
September 1, 2023: Journal of Hypertension
https://read.qxmd.com/read/37313863/changes-in-the-structure-and-function-of-the-left-ventricle-in-patients-with-gout-a-study-based-on-three-dimensional-speckle-tracking-echocardiography
#18
JOURNAL ARTICLE
Yuanyuan Meng, Leiyuan Ma, Tingyu Zong, Zhibin Wang
PURPOSE: Studies have shown that gout can increase the risk of cardiovascular disease. Three-dimensional speckle-tracking echocardiography (3D-STE), a sensitive imaging technology, enables the detection of subtle myocardial dysfunctions. Our aim is to evaluate the left ventricular (LV) functions in patients with gout using 3D-STE. METHODS: 80 subjects: 40 with gout and 40 as normal controls were involved. We obtained and analyzed these parameters from the dynamic images of a 3D full-volume dataset: global longitudinal strain (GLS), global circumferential strain (GCS), global radial strain (GRS), Twist, 16-segmental time-to-peak longitudinal strain (TTP) and systolic dyssynchrony index (SDI)besides other relevant parameters...
September 2023: Journal of Clinical Ultrasound: JCU
https://read.qxmd.com/read/37294239/surgical-management-of-tophaceous-gout-in-the-upper-limb
#19
JOURNAL ARTICLE
Daniel A Espinel, Diana C Martínez, María Á Gómez, David F Duque, Paula A Torres, Juliana V Rincón
PURPOSE: Gouty tophi are a clinical manifestation of hyperuricemia in advanced stages. They can produce pain, functional limitation, and severe deformities. Patients with severe symptoms require short-term symptomatic solutions that standard medical management is not able to provide. The objective of this study was to present the results obtained with the surgical management of tophaceous gout in the upper limb, as well as present a detailed characterization of the disease in the upper limb...
June 8, 2023: Journal of Hand Surgery
https://read.qxmd.com/read/37282649/recent-updates-on-transdermal-drug-delivery-approaches-for-the-management-of-gout-and-its-clinical-perspective
#20
JOURNAL ARTICLE
Ranjit K Harwansh, Soumya Mishra, Rupa Mazumder, Rohitas Deshmukh, Akhlaquer Rahman
Oral and injectable drug administration have recently been replaced with transdermal drug delivery (TDD) approaches, which are less intrusive, less likely to be rejected by patients, and easier to administer. There is still room for improvement in the treatment of gout with the use of a TDD system. Gout has become a worldwide epidemic and a severe threat to human beings. Gout treatment can be accomplished in various ways, including orally and intravenously. Several traditional options are still useless, cumbersome, and potentially dangerous...
June 6, 2023: Current Pharmaceutical Biotechnology
keyword
keyword
113128
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.